-
1
-
-
53049104252
-
-
Liu Z, Chen K, Davis C et al.: Drug delivery with carbon nanotubes for in vivo cancer treatment. Cancer Res. 68 (16), 6652-6660 (2008). ■ Discusses the potential use of carbon nanotubes as carriers of drugs for in vivo cancer treatment.
-
Liu Z, Chen K, Davis C et al.: Drug delivery with carbon nanotubes for in vivo cancer treatment. Cancer Res. 68 (16), 6652-6660 (2008). ■ Discusses the potential use of carbon nanotubes as carriers of drugs for in vivo cancer treatment.
-
-
-
-
2
-
-
38949105860
-
Functionalized carbon nanotubes in drug design and discovery
-
Prato M, Kostarelos K, Bianco A: Functionalized carbon nanotubes in drug design and discovery. Acc. Chem. Res. 41(1), 60-68 (2008).
-
(2008)
Acc. Chem. Res
, vol.41
, Issue.1
, pp. 60-68
-
-
Prato, M.1
Kostarelos, K.2
Bianco, A.3
-
3
-
-
42949087400
-
Carbon nanotubes filled with a chemotherapeutic agent: A nanocarrier mediates inhibition of tumor cell growth
-
Hampel S, Kunze D, Haase D et al.: Carbon nanotubes filled with a chemotherapeutic agent: a nanocarrier mediates inhibition of tumor cell growth. Nanomedicine 3(2), 175-182 (2008).
-
(2008)
Nanomedicine
, vol.3
, Issue.2
, pp. 175-182
-
-
Hampel, S.1
Kunze, D.2
Haase, D.3
-
4
-
-
0034434229
-
Design of two etoposide-amsacrine conjugates: Topoisomerase II and tubuline polymerization inhibition and relation to cytotoxicity
-
Arimondo P, Boukarim C, Bailly C et al.: Design of two etoposide-amsacrine conjugates: topoisomerase II and tubuline polymerization inhibition and relation to cytotoxicity. Anticancer Drug Des. 15 (6), 413-421 (2000).
-
(2000)
Anticancer Drug Des
, vol.15
, Issue.6
, pp. 413-421
-
-
Arimondo, P.1
Boukarim, C.2
Bailly, C.3
-
5
-
-
0036159856
-
Radiation enhancement by the combined use of topoisomerase I inhibitors, RFS-2000 or CPT-11, and topoisomerase II inhibitor etoposide in human lung cancer cells
-
Kim JS, Amorino GP, Pyo H et al.: Radiation enhancement by the combined use of topoisomerase I inhibitors, RFS-2000 or CPT-11, and topoisomerase II inhibitor etoposide in human lung cancer cells. Radiother. Oncol. 62 (1), 61-67 (2002).
-
(2002)
Radiother. Oncol
, vol.62
, Issue.1
, pp. 61-67
-
-
Kim, J.S.1
Amorino, G.P.2
Pyo, H.3
-
6
-
-
0037470042
-
A two-drug model for etoposide action against human topoisomerase IIα
-
Bromberg KD, Burgin AB, Osheroff N: A two-drug model for etoposide action against human topoisomerase IIα. J. Biol. Chem. 278 (9), 7406-7412 (2003).
-
(2003)
J. Biol. Chem
, vol.278
, Issue.9
, pp. 7406-7412
-
-
Bromberg, K.D.1
Burgin, A.B.2
Osheroff, N.3
-
7
-
-
41549130929
-
Newer cytotoxic agents: Attacking cancer broadly
-
Teicher BA: Newer cytotoxic agents: attacking cancer broadly. Clin. Cancer Res. 14(6), 1610-1617 (2008).
-
(2008)
Clin. Cancer Res
, vol.14
, Issue.6
, pp. 1610-1617
-
-
Teicher, B.A.1
-
8
-
-
0032449143
-
Oral etoposide for patients with advanced adenocarcinoma of the pancreas
-
Thomas E, Dumas EP, Ajani JA: Oral etoposide for patients with advanced adenocarcinoma of the pancreas. Invest. New Drugs 16(4), 333-335 (1999).
-
(1999)
Invest. New Drugs
, vol.16
, Issue.4
, pp. 333-335
-
-
Thomas, E.1
Dumas, E.P.2
Ajani, J.A.3
-
9
-
-
33751304141
-
Emetic potential of daily oral etoposide
-
Brames MJ, Einhorn LH: Emetic potential of daily oral etoposide. Support Care Cancer 14(12), 1262-1265 (2006).
-
(2006)
Support Care Cancer
, vol.14
, Issue.12
, pp. 1262-1265
-
-
Brames, M.J.1
Einhorn, L.H.2
-
10
-
-
6344238632
-
Low-dose oral etoposide-based induction regimen for children with acute lymphoblastic leukemia in first bone marrow relapse
-
Hijiya N, Gajjar A, Zhang Z et al.: Low-dose oral etoposide-based induction regimen for children with acute lymphoblastic leukemia in first bone marrow relapse. Leukemia 18, 1581-1586 (2004).
-
(2004)
Leukemia
, vol.18
, pp. 1581-1586
-
-
Hijiya, N.1
Gajjar, A.2
Zhang, Z.3
-
11
-
-
0034654517
-
The role of Apaf-1, caspase-9, and bid proteins in etoposide- or paclitaxel-induced mitochondrial events during apoptosis
-
Perkins CL, Guofu F, Caryn KN, Bhalla KN: The role of Apaf-1, caspase-9, and bid proteins in etoposide- or paclitaxel-induced mitochondrial events during apoptosis. Cancer Res. 60, 1645-1653 (2000).
-
(2000)
Cancer Res
, vol.60
, pp. 1645-1653
-
-
Perkins, C.L.1
Guofu, F.2
Caryn, K.N.3
Bhalla, K.N.4
-
12
-
-
18644369699
-
Caspase activation in etoposide-treated fibroblasts is correlated to ERK phosphorylation and both events are blocked by polyamine depletion
-
Stefanelli C, Tantinia B, Fattoria M et al.: Caspase activation in etoposide-treated fibroblasts is correlated to ERK phosphorylation and both events are blocked by polyamine depletion. FEBS Lett. 527(1), 223-228 (2002).
-
(2002)
FEBS Lett
, vol.527
, Issue.1
, pp. 223-228
-
-
Stefanelli, C.1
Tantinia, B.2
Fattoria, M.3
-
13
-
-
42649130001
-
Assessment of DNA double-strand breaks and γH2AX induced by the topoisomerase II poisons etoposide and mitoxantrone
-
Smart DJ, Halicka HD, Schmuck G et al.: Assessment of DNA double-strand breaks and γH2AX induced by the topoisomerase II poisons etoposide and mitoxantrone. Mutat Res. 641(1-2), 43-47 (2008).
-
(2008)
Mutat Res
, vol.641
, Issue.1-2
, pp. 43-47
-
-
Smart, D.J.1
Halicka, H.D.2
Schmuck, G.3
-
14
-
-
0034782735
-
p53 and redox state in etoposide-induced acute myeloblastic leukemia cell death
-
Koistinen P, Siitonen T, Mäntymaa P, Savolainen E: p53 and redox state in etoposide-induced acute myeloblastic leukemia cell death. Leukemia Res. 25(12), 1099-1105 (2001).
-
(2001)
Leukemia Res
, vol.25
, Issue.12
, pp. 1099-1105
-
-
Koistinen, P.1
Siitonen, T.2
Mäntymaa, P.3
Savolainen, E.4
-
15
-
-
34347228127
-
-
Long term oral etoposide as second line therapy in recurrent epithelial carcinoma of the ovary
-
Moosavi AS, Tehranian A, Behtash N et al.: Long term oral etoposide as second line therapy in recurrent epithelial carcinoma of the ovary. Acta Med. Iran. 44(1), 7-12 (2006).
-
(2006)
Acta Med. Iran
, vol.44
, Issue.1
, pp. 7-12
-
-
Moosavi, A.S.1
Tehranian, A.2
Behtash, N.3
-
16
-
-
61649122577
-
Phase II trial of estramustine phosphate and oral etoposide in patients with hormone-refractory prostate cancer
-
Spitaleri G, Matei DV, Curigliano G et al.: Phase II trial of estramustine phosphate and oral etoposide in patients with hormone-refractory prostate cancer. Ann. Oncol. 20(3), 498-502 (2009).
-
(2009)
Ann. Oncol
, vol.20
, Issue.3
, pp. 498-502
-
-
Spitaleri, G.1
Matei, D.V.2
Curigliano, G.3
-
17
-
-
0035106799
-
Phase II study of paclitaxel and oral etoposide in patients with locally advanced or metastatic non-small cell lung cancer
-
Boyer MJ, Mitchell P, Goldstein D et al.: Phase II study of paclitaxel and oral etoposide in patients with locally advanced or metastatic non-small cell lung cancer. Lung Cancer 32(1), 89 - 94 (2001).
-
(2001)
Lung Cancer
, vol.32
, Issue.1
, pp. 89-94
-
-
Boyer, M.J.1
Mitchell, P.2
Goldstein, D.3
-
18
-
-
0344393079
-
Mitochondria-targeting therapeutic strategies for overcoming chemoresistance and progression of cancer
-
Morisaki T, Katano M: Mitochondria-targeting therapeutic strategies for overcoming chemoresistance and progression of cancer. Curr. Med. Chem. 10(23), 2517-2521 (2003).
-
(2003)
Curr. Med. Chem
, vol.10
, Issue.23
, pp. 2517-2521
-
-
Morisaki, T.1
Katano, M.2
-
19
-
-
0035880232
-
Apaf-1 protein deficiency confers resistance to cytochrome c-dependent apoptosis in human leukemic cells
-
Li J, Srinivasula M, Feng-Ting L et al.: Apaf-1 protein deficiency confers resistance to cytochrome c-dependent apoptosis in human leukemic cells. Blood 98(2), 414-421 (2001).
-
(2001)
Blood
, vol.98
, Issue.2
, pp. 414-421
-
-
Li, J.1
Srinivasula, M.2
Feng-Ting, L.3
-
20
-
-
0037083593
-
Apoptosis induced by low-dose and low-dose-rate radiation
-
Mirzaie-Joniani H, Eriksson D, Sheikholvaezin A et al.: Apoptosis induced by low-dose and low-dose-rate radiation. Cancer 94(4), 1210-1214 (2002).
-
(2002)
Cancer
, vol.94
, Issue.4
, pp. 1210-1214
-
-
Mirzaie-Joniani, H.1
Eriksson, D.2
Sheikholvaezin, A.3
-
21
-
-
34147194094
-
Mitomycin C and etoposide in advanced colorectal carcinoma. A clinical and in vitro experience that focuses the problem of schedule dependence in combination therapy
-
Seminara P, Pastore C, Iascone C et al.: Mitomycin C and etoposide in advanced colorectal carcinoma. A clinical and in vitro experience that focuses the problem of schedule dependence in combination therapy. Chemotherapy 53(3), 218-225 (2007).
-
(2007)
Chemotherapy
, vol.53
, Issue.3
, pp. 218-225
-
-
Seminara, P.1
Pastore, C.2
Iascone, C.3
-
22
-
-
0038080911
-
Endoplasmic reticulum chaperone protein GRP78 protects cells from apoptosis induced by topoisomerase inhibitors
-
Reddy RK, Mao C, Baumeister P et al.: Endoplasmic reticulum chaperone protein GRP78 protects cells from apoptosis induced by topoisomerase inhibitors. J. Biol. Chem. 278(23), 20915-20924 (2003).
-
(2003)
J. Biol. Chem
, vol.278
, Issue.23
, pp. 20915-20924
-
-
Reddy, R.K.1
Mao, C.2
Baumeister, P.3
-
23
-
-
0037113881
-
Activation of Bak, Bax, and BH3-only proteins in the apoptotic response to doxorubicin
-
Panaretakis T, Pokrovskaja K, Shoshan MC, Grandér D: Activation of Bak, Bax, and BH3-only proteins in the apoptotic response to doxorubicin. J. Biol. Chem. 277(46), 44317-44326 (2002).
-
(2002)
J. Biol. Chem
, vol.277
, Issue.46
, pp. 44317-44326
-
-
Panaretakis, T.1
Pokrovskaja, K.2
Shoshan, M.C.3
Grandér, D.4
-
24
-
-
0037334117
-
-
Wen LT, Caldwell CC, Knowles AF: Poly(ADP-ribose)polymerase activation and changes in Bax protein expression associated with extracellular ATP-mediated apoptosis in human embryonic kidney 293-P2X7 cells. Mol. Pharmacol. 63(3), 706-713 (2003). ■ ATP (signaling factor) treatment induced a significant increase in apoptotic embryonic kidney cells and was related to the Bax protein expressions.
-
Wen LT, Caldwell CC, Knowles AF: Poly(ADP-ribose)polymerase activation and changes in Bax protein expression associated with extracellular ATP-mediated apoptosis in human embryonic kidney 293-P2X7 cells. Mol. Pharmacol. 63(3), 706-713 (2003). ■ ATP (signaling factor) treatment induced a significant increase in apoptotic embryonic kidney cells and was related to the Bax protein expressions.
-
-
-
-
25
-
-
0024233051
-
Mechanism of action of anti-tumor drug etoposide: A review
-
van Maanen JM, Retèl J, de Vries J, Pinedo HM: Mechanism of action of anti-tumor drug etoposide: a review. J. Natl Cancer Inst. 80(19), 1526-1533 (1988).
-
(1988)
J. Natl Cancer Inst
, vol.80
, Issue.19
, pp. 1526-1533
-
-
van Maanen, J.M.1
Retèl, J.2
de Vries, J.3
Pinedo, H.M.4
-
26
-
-
39149109651
-
Etoposide-resistant HT-29 human colon carcinoma cells during glucose deprivation are sensitive to piericidin A, a GRP78 down-regulator
-
Hwang JH, Kim JY, Cha MI et al.: Etoposide-resistant HT-29 human colon carcinoma cells during glucose deprivation are sensitive to piericidin A, a GRP78 down-regulator. J. Cell Physiol. 215(1), 243-250 (2008).
-
(2008)
J. Cell Physiol
, vol.215
, Issue.1
, pp. 243-250
-
-
Hwang, J.H.1
Kim, J.Y.2
Cha, M.I.3
-
27
-
-
0035843169
-
Inactivation of the apoptosis effector Apaf-1 in malignant melanoma
-
Discusses that metastatic melanomas could have Apaf-1 (cell death effector) inactivated, to mediate apoptosis, ■■
-
Soengas MS, Capodieci P, Polsky D et al.: Inactivation of the apoptosis effector Apaf-1 in malignant melanoma. Nature 409, 207-211 (2001). ■■ Discusses that metastatic melanomas could have Apaf-1 (cell death effector) inactivated, to mediate apoptosis.
-
(2001)
Nature
, vol.409
, pp. 207-211
-
-
Soengas, M.S.1
Capodieci, P.2
Polsky, D.3
-
28
-
-
0037012034
-
Caspase 9 is required for p53-dependent apoptosis and chemosensitivity in a human ovarian cancer cell line
-
Wu GS, Ding Z: Caspase 9 is required for p53-dependent apoptosis and chemosensitivity in a human ovarian cancer cell line. Oncogene 21(1), 1-8 (2002)
-
(2002)
Oncogene
, vol.21
, Issue.1
, pp. 1-8
-
-
Wu, G.S.1
Ding, Z.2
-
29
-
-
0034569391
-
Inducible resistance to Fas-mediated apoptosis in B cells
-
Rothstein TL: Inducible resistance to Fas-mediated apoptosis in B cells. Cell Res. 10, 245-266 (2000).
-
(2000)
Cell Res
, vol.10
, pp. 245-266
-
-
Rothstein, T.L.1
-
30
-
-
25844464705
-
Single-walled carbon nanotube induces oxidative stress and activates nuclear transcription factor-kb in human keratinocytes
-
Manna SK, Sarkar S, Barr J et al.: Single-walled carbon nanotube induces oxidative stress and activates nuclear transcription factor-kb in human keratinocytes. Nano Lett. 5(9), 1676-1684 (2005).
-
(2005)
Nano Lett
, vol.5
, Issue.9
, pp. 1676-1684
-
-
Manna, S.K.1
Sarkar, S.2
Barr, J.3
-
31
-
-
3042818668
-
Nanotube molecular transporters: Internalization of carbon nanotube-protein conjugates into mammalian cells
-
Shi Kam NW, Jessop TC, Wender PA et al.: Nanotube molecular transporters: internalization of carbon nanotube-protein conjugates into mammalian cells. J. Am. Chem. Soc. 22(126), 6850-6851 (2004).
-
(2004)
J. Am. Chem. Soc
, vol.22
, Issue.126
, pp. 6850-6851
-
-
Shi Kam, N.W.1
Jessop, T.C.2
Wender, P.A.3
-
32
-
-
31944451232
-
Toxic potential of materials at the nanolevel
-
Andre N, Tian X, Lutz M, Ning L: Toxic potential of materials at the nanolevel. Science 311, 622-627 (2006).
-
(2006)
Science
, vol.311
, pp. 622-627
-
-
Andre, N.1
Tian, X.2
Lutz, M.3
Ning, L.4
-
33
-
-
40349112868
-
Circulation and long-term fate of functionalized, biocompatible single-walled carbon nanotubes in mice probed by Raman spectroscopy
-
Describes the biodistribution of carbon nanotubes into various organs and tissues based on their unique Raman signature, ■■
-
Liu Z, Davis C, Cai W, He L, Chen X, Dai H: Circulation and long-term fate of functionalized, biocompatible single-walled carbon nanotubes in mice probed by Raman spectroscopy. Proc. Natl Acad. Sci. USA 105(5), 1410-1415 (2008). ■■ Describes the biodistribution of carbon nanotubes into various organs and tissues based on their unique Raman signature.
-
(2008)
Proc. Natl Acad. Sci. USA
, vol.105
, Issue.5
, pp. 1410-1415
-
-
Liu, Z.1
Davis, C.2
Cai, W.3
He, L.4
Chen, X.5
Dai, H.6
-
34
-
-
58149293968
-
Quantum dots as multimodal photoacoustic and photothermal contrast agents
-
Shashkov EV, Everts M, Galanzha EI, Zharov VP: Quantum dots as multimodal photoacoustic and photothermal contrast agents. Nano Lett. 8(11), 3953-3958 (2008).
-
(2008)
Nano Lett
, vol.8
, Issue.11
, pp. 3953-3958
-
-
Shashkov, E.V.1
Everts, M.2
Galanzha, E.I.3
Zharov, V.P.4
-
35
-
-
67349198099
-
Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of docetaxel
-
Feng SS, Mei L, Anitha P, Gan CW, Zhou W: Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of docetaxel. Biomaterials 30, 3297-3306 (2009).
-
(2009)
Biomaterials
, vol.30
, pp. 3297-3306
-
-
Feng, S.S.1
Mei, L.2
Anitha, P.3
Gan, C.W.4
Zhou, W.5
-
36
-
-
20444416355
-
Poly(D,L-lactide-coglycolide)/montmorillonite nanoparticles for oral delivery of anticancer drugs
-
Dong Y, Feng SS: Poly(D,L-lactide-coglycolide)/montmorillonite nanoparticles for oral delivery of anticancer drugs. Biomaterials 26, 6068-6076 (2005).
-
(2005)
Biomaterials
, vol.26
, pp. 6068-6076
-
-
Dong, Y.1
Feng, S.S.2
|